Monitoring antimalarial safety and tolerability in clinical trials: A case study from Uganda
Monitoring antimalarial safety and tolerability in clinical trials: A case study from Uganda
About this item
Full title
Author / Creator
Staedke, Sarah G , Jagannathan, Prasanna , Yeka, Adoke , Bukirwa, Hasifa , Banek, Kristin , Maiteki-Sebuguzi, Catherine , Clark, Tamara D , Nzarubara, Bridget , Njama-Meya, Denise , Mpimbaza, Arthur , Rosenthal, Philip J , Kamya, Moses R , Wabwire-Mangen, Fred , Dorsey, Grant and Talisuna, Ambrose O
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
New antimalarial regimens, including artemisinin-based combination therapies (ACTs), have been adopted widely as first-line treatment for uncomplicated malaria. Although these drugs appear to be safe and well-tolerated, experience with their use in Africa is limited and continued assessment of safety is a priority. However, no standardized guidelin...
Alternative Titles
Full title
Monitoring antimalarial safety and tolerability in clinical trials: A case study from Uganda
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_1579316d05f043ccbc00700746007b67
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1579316d05f043ccbc00700746007b67
Other Identifiers
ISSN
1475-2875
E-ISSN
1475-2875
DOI
10.1186/1475-2875-7-107
